American ginseng does not improve fatigue in multiple sclerosis: a randomized double-blind placebo-controlled crossover study.
This study examined the safety and efficacy of an escalating dose (100 mg, 200 mg, 400 mg/day) of American ginseng over 6 weeks in 56 MSers with fatigue. There were no serious adverse events but fatigue on ginsengwas not significantly different from fatigue on placebo.
‘Aspirin for Treatment of MS-Related Fatigue’ Trial:
ReplyDeletehttp://clinicaltrials.gov/ct2/show/NCT00467584
This phase III trial was started in 2007 and is due to report in 2012. Does anyone know if this is the first trial of its kind?